Published in Agents Actions Suppl on January 01, 1986
5-Ethyl-4-methyl-1H-pyrazol-3(2H)-one. Acta Crystallogr Sect E Struct Rep Online (2010) 1.67
Tert-butyl 3-oxo-2,3,4,5,6,7-hexa-hydro-1H-pyrazolo[4,3-c]pyridine-5-carboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2009) 1.47
Characterizing the network of drugs and their affected metabolic subpathways. PLoS One (2012) 0.92
3-Ethyl-4-phen-oxy-1-(2,2,2-trifluoro-eth-yl)-1H-pyrazol-5-ol. Acta Crystallogr Sect E Struct Rep Online (2010) 0.75
Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med (1999) 3.57
Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. Thromb Res (1980) 2.68
Assessment of phagocytic and antimicrobial activity of human granulocytes. Infect Immun (1974) 1.96
Afferent nerve-mediated protection against deep mucosal damage in the rat stomach. Gastroenterology (1990) 1.94
Quantitative detection of Borrelia burgdorferi by real-time PCR. J Clin Microbiol (1999) 1.93
The venous graft as an effector of early angiogenesis in a fibrin matrix. Microvasc Res (2007) 1.93
Women encounter ADRs more often than do men. Eur J Clin Pharmacol (2008) 1.83
Release of leukotriene C4 from human polymorphonuclear leucocytes as determined by radioimmunoassay. FEBS Lett (1982) 1.66
Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats. Physicochemical and biochemical factors involved. Arch Toxicol (1990) 1.59
Evidence for a direct stimulatory effect of prostacyclin on renin release in man. J Clin Invest (1982) 1.57
Prostaglandin and thromboxane synthesis in a pure macrophage population and the inhibition, by E-type prostaglandins, of chemiluminescence. FEBS Lett (1978) 1.55
Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf (2000) 1.51
Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. Br J Pharmacol (1998) 1.44
Pharmacological control of prostaglandin and thromboxane release from macrophages. Nature (1978) 1.44
Modulation of pulmonary vascular resistance and edema formation by short-term infusion of a 10% fish oil emulsion. Infusionsther Transfusionsmed (1993) 1.43
Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med (2004) 1.42
Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol (2000) 1.42
Prostaglandin, slow-reacting substance, and histamine release from anaphylactic guinea-pig hearts, and its pharmacological modification. Naunyn Schmiedebergs Arch Pharmacol (1975) 1.40
Peroxidaseless chicken leukocytes: isolation and characterization of antibacterial granules. J Infect Dis (1973) 1.39
Bitter pill to swallow over medical education. Nature (1998) 1.39
Inhibition of anti-inflammatory drugs of prostaglandin production in cultured macrophages. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.36
Leukocytes and prostaglandins in acute inflammation. Experientia (1974) 1.35
Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett (1996) 1.30
Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn's disease: inhibition by sulfasalazine and 5-aminosalicylic acid. Agents Actions (1986) 1.29
Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives. Gut (2001) 1.29
Elevated serum cyclophilin levels in patients with severe sepsis. J Clin Immunol (1997) 1.28
Pulmonary hypertension correlated to pulmonary thromboxane synthesis. Adv Prostaglandin Thromboxane Res (1980) 1.25
Computerized surveillance of adverse drug reactions in hospital: implementation. Eur J Clin Pharmacol (1999) 1.24
Ethanol stimulates formation of leukotriene C4 in rat gastric mucosa. Prostaglandins (1986) 1.19
Release of prostaglandins, a prostaglandin metabolite, slow-reacting substance and histamine from anaphylactic lungs, and its modification by catecholamines. Naunyn Schmiedebergs Arch Pharmacol (1974) 1.19
Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin. Am J Physiol (1995) 1.18
Synthesis and release of prostaglandins by rat brain synaptosomal fractions. J Neurochem (1976) 1.17
Possible role of oxygen free radicals in ethanol-induced gastric mucosal damage in rats. Dig Dis Sci (1988) 1.17
On the synthesis of prostaglandins by human gastric mucosa and its modification by drugs. Biochim Biophys Acta (1977) 1.16
Role of calcitonin gene-related peptide and nitric oxide in the gastroprotective effect of capsaicin in the rat. Gastroenterology (1993) 1.14
Release of calcitonin gene-related peptide induced by capsaicin in the vascularly perfused rat stomach. Neurosci Lett (1990) 1.13
Biodistribution of mild analgesics. Br J Clin Pharmacol (1980) 1.12
Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet. Clin Pharmacol Ther (2002) 1.12
Effect of carbenoxolone on prostaglandin synthesis and degradation. J Pharm Pharmacol (1976) 1.12
Acidic nonsteroid anti-inflammatory drugs accumulating in inflamed tissue. Experientia (1975) 1.11
Microbicidal activity of peroxidaseless chicken heterophile leukocytes. Infect Immun (1972) 1.10
Correlation between antimicrobial activity and peroxidase content of leukocytes. Nature (1973) 1.10
Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals. Br J Clin Pharmacol (1999) 1.10
Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method. Br J Anaesth (1993) 1.10
Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats. Dig Dis Sci (1993) 1.10
The effect of parenteral fish oil on leukocyte membrane fatty acid composition and leukotriene-synthesizing capacity in patients with postoperative trauma. Metabolism (1996) 1.09
Control of arachidonic acid accumulation in bone marrow-derived macrophages by acyltransferases. J Biol Chem (1981) 1.09
Prostaglandin release from macrophages: an assay system for anti-inflammatory drugs in vitro. Agents Actions (1977) 1.08
Prostaglandin E(2) upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages. Biochem Biophys Res Commun (2000) 1.08
Selective cyclo-oxygenase-2 inhibitors aggravate ischaemia-reperfusion injury in the rat stomach. Br J Pharmacol (1999) 1.07
Effects of pentazocine and acetylsalicylic acid on pain-rating, pain-related evoked potentials and vigilance in relationship to pharmacokinetic parameters. Agents Actions (1990) 1.06
Stereoselective disposition of flurbiprofen in healthy subjects following administration of the single enantiomers. Br J Clin Pharmacol (1994) 1.05
Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Invest Dermatol (1986) 1.04
Radioimmunological determination of thromboxane release in cardiac anaphylaxis. Eur J Pharmacol (1977) 1.04
Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs. A survey of their analgesic efficacy. Drugs (1991) 1.04
Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge. Br J Pharmacol (2001) 1.03
Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons. Eur J Pharmacol (1992) 1.02
Chemiluminescence and immune cell activation. I. Early activation of rat thymocytes can be monitored by chemiluminescence measurements. Eur J Immunol (1978) 1.02
Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration. Clin Pharmacol Ther (1999) 1.01
Serum antibodies against chondrocyte cell surface proteins in osteoarthritis and rheumatoid arthritis. J Rheumatol (1988) 1.01
Computerized survelliance of adverse drug reactions in hospital: pilot study. Br J Clin Pharmacol (1998) 1.00
Suppressed injury-induced rise in spinal prostaglandin E2 production and reduced early thermal hyperalgesia in iNOS-deficient mice. J Neurosci (2000) 0.99
Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E(2), and nonsteroidal anti-inflammatory drugs. Biochem Biophys Res Commun (2000) 0.99
Effects of pure enantiomers of flurbiprofen in comparison to racemic flurbiprofen on eicosanoid release from various rat organs ex vivo. Prostaglandins (1991) 0.99
Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition. Experientia (1991) 0.99
Non-acidic pyrazoles: inhibition of prostaglandin production, carrageenan oedema and yeast fever. Agents Actions (1983) 0.98
Inflammatory models of cutaneous hyperalgesia are sensitive to effects of ibuprofen in man. Pain (1995) 0.98
Role of the parietal cell in gastric damage induced by aspirin and related drugs: implications for safer therapy. Med J Aust (1976) 0.97
How aspirin might work: a pharmacokinetic approach. Agents Actions (1974) 0.97
Pharmacological modification of thromboxane and prostaglandin release in cardiac anaphylaxis. Prostaglandins (1978) 0.97
Leukotriene synthesis by human gastrointestinal tissues. Biochim Biophys Acta (1986) 0.95
Non-steroid anti-inflammatory drugs: influence of extra-cellular pH on biodistribution and pharmacological effects. Biochem Pharmacol (1978) 0.95
Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach. Br J Pharmacol (1998) 0.95
In vitro release of prostaglandins and leukotrienes from synovial tissue, cartilage, and bone in degenerative joint diseases. Arthritis Rheum (1993) 0.95
[Treatment of tension-type headache. Recommendation of the German Migraine and Headache Society]. Schmerz (1998) 0.95
Therapeutically relevant differences in the pharmacokinetical and pharmaceutical behavior of ibuprofen lysinate as compared to ibuprofen acid. Int J Clin Pharmacol Ther Toxicol (1989) 0.95
Stimulation of rat gastric mucosal leukotriene C4 formation by ethanol and effect of gastric protective drugs. Adv Prostaglandin Thromboxane Leukot Res (1987) 0.94
Pharmacokinetics of S(+)- and R(-)-ibuprofen in volunteers and first clinical experience of S(+)-ibuprofen in rheumatoid arthritis. Eur J Clin Pharmacol (1990) 0.94
High-performance liquid chromatographic determination of ibuprofen, its metabolites and enantiomers in biological fluids. J Chromatogr (1989) 0.94
Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration. Clin Pharmacol Ther (1999) 0.94
Ibuprofen as an over-the-counter drug: is there a risk for renal injury? Clin Nephrol (1993) 0.94
Synthesis and metabolism of endogenous prostaglandins by human gastric mucosa. Adv Prostaglandin Thromboxane Res (1980) 0.94
Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes. Invest Ophthalmol Vis Sci (2001) 0.93